布地奈德联合氨茶碱治疗小儿毛细支气管炎效果评价.docVIP

  • 2
  • 0
  • 约3.96千字
  • 约 8页
  • 2018-07-05 发布于福建
  • 举报

布地奈德联合氨茶碱治疗小儿毛细支气管炎效果评价.doc

布地奈德联合氨茶碱治疗小儿毛细支气管炎效果评价

布地奈德联合氨茶碱治疗小儿毛细支气管炎效果评价      [摘要] 目的 观察布地奈德联合氨茶碱治疗小儿毛细支气管炎的临床效果。 方法 选取2012年7月~2013年6月本院收治的120例毛细支气管炎患儿,随机分为3组,每组40例,对照组采用常规基础治疗,实验组1在对照组基础上实施雾化吸入布地奈德混悬液治疗,实验组2在实验组1的基础上加用氨茶碱治疗,观察3组的疗效及不良反应。 结果 实验组1、2的治愈率分别为80.0%、97.5%,明显高于对照组的62.5%,且实验组2高于实验组1;住院时间及咳嗽、湿?音、哮鸣音消失时间明显短于对照组,且实验组2短于实验组1(P<0.05)。 结论 布地奈德联合氨茶碱治疗小儿毛细支气管炎的效果确切,可有效提高治愈率,缩短疗程,安全性高,值得推广。   [关键词] 毛细支气管炎;氨茶碱;布地奈德   [中图分类号] R562.2+1[文献标识码] A[文章编号] 1674-4721(2014)03(c)-0071-03      Effect evaluation of budesonide combining with aminophylline in the treatment of capillary bronchitis in children   QIN Wei TAN Dao-xiang ZHENG Yong-qian SHI Wen-die LI Ya ZENG Shuang-zhi   Department of Pediatrics,Shipai Hospital of Dongguan City in Guangdong Province,Dongguan 523330,China   [Abstract] Objective To observe the clinical effect of budesonide combining with aminophylline in the treatment of child capillary bronchitis. Methods 120 child patients with capillary bronchitis admitted into our hospital from July 2012 to June 2013 were selected and evenly divided into three groups in random.In control group,conventional treatment was provided.In experimental group Ⅰ,besides treatment in control group,aerosol inhalation of budesonide suspension was applied.In experimental group Ⅱ,on the basis of treatment in the experimental group Ⅰ,aminophylline was added.The curative effects and adverse reaction were observed among three groups. Results The cure rates in the experimental group Ⅰ and Ⅱ were 80.0% and 97.5% respectively,which were much higher than that in the control group accounting for 62.5%.The cure rate in the experimental group Ⅱ was higher than that in the experimental group Ⅰ.The hospital stay and disappearance time of cough,moist rale,and wheeze in experimental groups were remarkably shorter than those in the control group.These indicators in the experimental group Ⅱ were shorter in comparison with those in the experimental group Ⅰ(P   1.3 疗效评定标准[4]   治愈:治疗7 d后患儿心率<120/min,呼吸频率<40/min,全部临床症状消失,肺部无湿?音和哮鸣音;好转:治疗7 d后患儿肺部湿?音

文档评论(0)

1亿VIP精品文档

相关文档